We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Tourmaline Bio Inc | NASDAQ:TRML | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.4303 | 3.15% | 14.0903 | 12.48 | 15.00 | 13.88 | 13.41 | 13.59 | 326,966 | 05:00:04 |
Jefferies Biotech on the Bay Summit, MiamiOne-on-one and Small Group Meetings March 12, 2024
Leerink Global Biopharma Conference, MiamiCorporate PresentationMarch 13, 2024 at 10:00am ET
Live webcasts and replays, if available, will be posted under "Events and Presentations" in the News & Investors section of the Tourmaline Bio website at https://ir.tourmalinebio.com.
About Tourmaline Bio, Inc. Tourmaline is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune and inflammatory diseases. Tourmaline’s lead asset is TOUR006.
About TOUR006TOUR006 is a long-acting, fully-human, anti-IL-6 monoclonal antibody with best-in-class potential and differentiated properties including a naturally long half-life, low immunogenicity, and high binding affinity to IL-6. To date, TOUR006 has been studied in 448 participants, including patients with autoimmune disorders, across six clinical trials. Tourmaline is developing TOUR006 in Thyroid Eye Disease (TED) and Atherosclerotic Cardiovascular Disease (ASCVD) as its first two indications, with additional diseases under consideration.
Contact:
Meru AdvisorsLee M. Sternlstern@meruadvisors.com
1 Year Tourmaline Bio Chart |
1 Month Tourmaline Bio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions